Synopsis

Source of validity: Scientific
Rating (out of 5): 2

AMP-activated protein kinase (AMPK) is an enzyme that acts as a key regulator of cellular energy homeostasis. Recent scientific research has explored its potential role in treating peripheral neuropathy, particularly neuropathies associated with metabolic dysfunctions like diabetes. Peripheral neuropathy involves damage to peripheral nerves, often resulting from oxidative stress, mitochondrial dysfunction, and impaired energy metabolism—pathways in which AMPK plays a regulatory role.

Preclinical studies in animal models have shown that activation of AMPK, either pharmacologically (e.g., with metformin or AICAR) or genetically, can alleviate some neuropathic symptoms. These benefits are thought to arise from AMPK’s ability to enhance mitochondrial function, reduce inflammation, and decrease oxidative stress in neural tissues. For example, several rodent studies have demonstrated that AMPK activators can reduce pain sensitivity and improve nerve conduction in models of diabetic neuropathy.

However, clinical evidence in humans remains limited. While metformin, a common AMPK activator, is sometimes associated with reduced neuropathy risk in diabetic patients, it is difficult to separate its direct AMPK-mediated effects from its glucose-lowering properties. No large, well-controlled trials have directly tested AMPK activators specifically for peripheral neuropathy in humans. Therefore, while the mechanistic rationale and preclinical evidence are promising, the overall evidence supporting AMPK modulation as a treatment for peripheral neuropathy is still preliminary, meriting a moderate rating (2/5) for scientific support.

More about AMP-activated protein kinase (AMPK)
More about Peripheral Neuropathy

Other ingredients used for Peripheral Neuropathy

Other health conditions supported by AMP-activated protein kinase (AMPK)

Products containing AMP-activated protein kinase (AMPK)